MedPath

Association of Acanthosis Nigricans and Insulin Resistance as determined by Homeostasis Model Assessment 2 Software

Not Applicable
Conditions
Health Condition 1: L83- Acanthosis nigricans
Registration Number
CTRI/2024/02/062243
Lead Sponsor
Bharati Vidyapeeth (Deemed to be University) Medical College, Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex and all ages

-Patients who are clinically diagnosed with acanthosis nigricans attending Dermatology OPD at Bharati hospital

Exclusion Criteria

-Patients with previously diagnosed type 1 or type 2 diabetes mellitus

-Patients with known endocrinopathies and those with skin disorders known to be associated with Metabolic Syndrome (psoriasis, lichen planus, polycystic ovarian syndrome) will not be included in the study

-Patients who are pregnant or lactating

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the association of insulin resistance in acanthosis nigricans patients <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: At the time of recruitment of study participant will be advised serum fasting blood glucose and serum fasting insulin levels <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To calculate prevalence insulin resistance in patients presenting with acanthosis nigricans. <br/ ><br>Timepoint: After completion of recruitment of study participants;To correlate insulin resistance with severity of lesions using scoring scale for acanthosis nigricans by Burke et al. <br/ ><br>Timepoint: After completion of recruitment of study participants;To study the association of insulin resistance with BMI according to WHO classificationTimepoint: After completion of recruitment of study participants
© Copyright 2025. All Rights Reserved by MedPath